ArticlePharmacotherapy2025

Real-World Use of Letermovir and Maribavir for CMV Prophylaxis and Treatment in Solid Organ Transplant Recipients: Clinical Outcomes and Resistance Patterns From a Dual-Center Cohort.

Man Ting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.